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ABSTRACT 1 
Background 2 
Limited research exists for the effects of neurodynamic treatment techniques. 3 
Understanding short term physiological outcomes could help to better understand 4 
immediate benefits or harm of treatment.  5 
 6 
Objectives 7 
To assess the short-term effects of a straight leg raise (SLR) tensioner on pressure pain 8 
thresholds (PPT) and vibration thresholds (VT), and establish if additional factors influence 9 
outcome in individuals with spinally referred leg pain. 10 
Design 11 
Experimental, repeated measures. 12 
Methods 13 
Sixty seven participants (mean age (SD) 52.9 (13.3), 33 female) with spinally referred leg 14 
pain were divided into 3 sub-groups: somatic referred pain, radicular pain and 15 
radiculopathy. Individuals were assessed for central sensitisation (CS) and completed 5 16 
disability and psychosocial questionnaires. PPT and VT were measured pre and post a 3 x 1 17 
minute SLR tensioner intervention.  18 
Results 19 
No significant differences (p>0.05) were found between the 3 groups for either outcome 20 
measure, or after treatment. Slight improvements in VT were seen in the radiculopathy 21 
group after treatment, but were not significant. Only 2 participants were identified with CS. 22 
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Disability and psychological factors were not significantly different at baseline between the 23 
3 sub-groups, and did not correlate with the outcome measures.     24 
Conclusions 25 
No beneficial effects of treatment were found, but the trend for a decrease in VT indicated 26 
that even in individuals with radiculopathy, no detrimental changes to nerve function 27 
occurred.  Psychosocial factors and levels of disability did not influence short term outcome 28 
of SLR treatment. 29 
Key Words: Neurodynamics; Nerve function; Pressure pain thresholds; Spinally referred 30 
leg pain; Straight leg raise. 31 
 32 
TEXT 33 
INTRODUCTION 34 
Spinally referred leg pain predominantly occurs from nociceptive referral of spinal 35 
structures such as ligaments, muscles and disc (somatic)1 or neural tissue. Where loss of 36 
nerve function is found, this is described as radiculopathy, whereas nerve root irritation 37 
without loss of nerve function is termed radicular pain1. The management of such 38 
conditions varies, but for individuals where nerve root irritation is present, neurodynamic 39 
treatment (NDT) has been proposed. 2,3  40 
Adding NDT treatments to other techniques for spinally referred leg pain has shown some 41 
benefits 2,4,5, however it is not known why such improvements in outcome occur. 42 
Limitations of the studies do not clarify the reason for the improvements. Some authors 43 
have suggested that applying NDT tensioner techniques to individuals with neuropathic 44 
pain may have detrimental effects 6,7.  In contrast, recent animal studies have indicated that 45 
tensioner techniques not only positively influence pain behaviours, but may also have 46 
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positive effects on inflammatory cells within the dorsal horn. 8,9   Such gaps on the effects of 47 
NDT in the literature and potential for detrimental changes require further investigation. 48 
 Change in pain is an essential measurement when assessing the effects of treatment 49 
interventions, and pressure pain thresholds (PPT) are widely used within the literature. 10,11 50 
PPT are reliable 12,13  and provide a semi-objective measure of pain. However, pain changes 51 
alone only give an indication of one aspect of outcome. In individuals with neuropathic 52 
pain, changes to nerve function after NDT are important because inducing strain to the 53 
nerve of greater than 8% may reduce circulation 14,15, and impair nerve conduction 16,17. 54 
Whilst small levels of strain have been found in the nerve roots during SLR in cadavers 55 
(<3.4% 18), neuropathy may detrimentally affect normal nerve mechanics 6,19. 56 
 Vibration thresholds (VT) have been utilised as an early indicator of deterioration in nerve 57 
function. They are more useful than nerve conduction testing because they are sensitive to 58 
minor nerve dysfunction and specifically test the large diameter afferents, which deteriorate 59 
after nerve root compression 20,21.  60 
Treatment outcomes may be affected by a number of variables, including high levels of 61 
disability 23,24 and psychosocial factors 25,26. The presence of central sensitisation (CS) is 62 
also considered to be a poor predictor of outcome for manual based interventions. 27 It isn’t 63 
known whether these factors influence the physiological responses to NDT.  64 
The aim of this study was to assess the short term effects of a SLR tensioner technique on 65 
PPT and VT in individuals with spinally referred leg pain, and to establish if certain factors 66 
had an impact on outcome. Whilst short term outcomes have limitations in terms of 67 
extrapolation into clinical practice, this study looked at what factors might impact on these 68 
physiological measures in different sub-groups of individuals with spinally referred leg 69 
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pain, rather than looking at the overall effectiveness of treatment, where long term and 70 
functional outcomes are most desirable.  71 
 72 
METHODS 73 
The study received ethics approval from the host university’s Faculty of Health and Social 74 
Science Ethics and Governance panel, and the UK’s NHS ethics panel (REC reference 75 
12/LO/0397). 76 
Participants 77 
Participants were recruited from Physiotherapy waiting lists of 3 NHS trusts in the South 78 
East region of the UK. Participants who were not currently undergoing treatment for their 79 
pain were also recruited via University email and adverts in local newspapers. Participants 80 
were included if they had spinally referred leg pain for greater than 3 months,  without 81 
other medical problems such as diabetes, rheumatoid arthritis or other systemic disorders. 82 
All participants were given an information sheet and signed a consent form prior to 83 
commencement in the study. The participants attended 2 sessions; the first to sub- group  84 
and ensure their eligibility and the second was the experimental stage of the study.  85 
Sub-grouping 86 
Participants were assessed by one of 6 experienced Physiotherapists with at least 4 years’ 87 
experience in musculoskeletal practice. Training was given to all Physiotherapists prior to 88 
the commencement of the study. 89 
Full subjective and physical examinations of each participant were performed, before 90 
allocating each individual into one of 3 sub-groups (Figure 1). If participants complained of 91 
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more than 2 signs of CS (pain > 6 months 28, widespread areas of pain 26, hypersensitivity 92 
to warmth or cold29, and hypersensitivity to touch 26,28), an examination of painful points 93 
was undertaken (Figure 2). The algometer (Wagner FPK, Greenwich, USA) was placed on 94 
each of the points, and the pressure increased up to 4kg/cm². If more than 8 of the points 95 
were painful, the participants were considered to have CS.26   96 
 97 
 98 
 99 
 100 
 101 
 102 
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1. Patient with suspected spinally referred leg pain 
2. Pain reproduced on spinal 
movements and spinal 
accessory movements# 
EXCLUDE EXCLUDE 
3. Positive SLR or slump test 
with structural differentiation 
Severe and 
irritable* 
NO 
4. Positive neurological integrity 
(no more than 2 adjacent 
segments) 
YES 
NO 
SOMATIC 
REFERRED PAIN 
RADICULAR 
PAIN 
YES 
NO 
YES 
RADICULOPATHY 
EXCLUDE URGENT 
REFERRAL 
>2 levels or S+S 
Cauda equina 
5. > 2 S+S of central 
sensi=sa=on?⁺ 
Not centrally 
sensitised 
6. > 8 tender points tested with 
algometer? 
Not centrally 
sensitised 
Centrally sensitised 
YES 
YES 
NO 
NO 
* severity based on patient’s ability to be able to sustain their painful position. Irritability 
based on time to aggravate and time to ease symptoms on simple planar movements 
(Petty, 2011). 
# If pain not reproduced on planar movements, combined, repeated or sustained 
movements performed.  PAIVMS performed in provocative position where indicated. 
⁺S+S central sensitisation- pain> 6 months, widespread areas of pain, hypersensitivity to 
warmth, cold or touch. 
See 
step 5 
See 
step 5 
 103 
FIGURE 1 flow chart of sub-grouping procedure104 
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 105 
FIGURE 2 Tender point assessment 106 
Experimental Stage 107 
Participants attended the laboratory a minimum of 48 hours after their initial assessment.  108 
Participants filled out 5 questionnaires: Fear avoidance belief questionnaire (FABQ), 109 
Tampa scale of kinesiophobia, Oswestry disability index (ODI), Depression, anxiety and 110 
stress scale (DASS), and Pain catastrophising scale (PCS). 111 
Height and weight measurements were taken of all participants. The order of PPT or VT 112 
measurements was randomly allocated by asking participants to choose a piece of paper 113 
from a bag written with either V or P.  All measures were taken by one researcher blinded 114 
to the group allocation of participants.  115 
 116 
 117 
 118 
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Vibration threshold testing 119 
Participants lay prone and a practice VT was obtained from the unaffected side on the 120 
plantar surface of the base of the first metatarsal using a vibrameter (Somedic AB, 121 
Sweden). The probe was placed perpendicular on the metatarsal so that the weight of the 122 
probe rested fully on the area. Vibration was slowly increased until the participant felt the 123 
onset. The stimulus was then increased before being reduced again until the participant 124 
could no longer feel the sensation. Once a consistent measure (within 10%) had been 125 
demonstrated, VT readings were taken from the same site on the affected side. Three 126 
vibration appearance values and 3 vibration disappearance values were taken. The 127 
participant was then asked to lie on their unaffected side and VT readings were taken from 128 
the lateral malleolus of the affected side.  129 
Pressure Pain Thresholds 130 
Participants lay prone and a practice PPT was taken from the unaffected leg with a tracker 131 
freedom wireless algometer (J Tech Medical, Salt Lake City, U.S.A.) over the 132 
gastrocnemius belly and tibial nerve to familiarise the participant to PPT. 133 
PPTs were taken from the middle portion of the deltoid muscle on the unaffected side, the 134 
tibial nerve behind the knee, and gastrocnemius (a point marked one third of the distance 135 
between the knee crease to the top of the calcaneal tuberosity) on the affected side.  136 
Participants lay on their affected side and the probe placed perpendicular to middle portion 137 
of deltoid with pressure applied at the rate indicated by the pacer (1kg/sec). Participants 138 
were asked to push a hand plate when the sensation of pressure changed to one of 139 
discomfort. The participant turned prone and the same procedure was repeated for the tibial 140 
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nerve behind the knee, before moving on to the gastrocnemius point. Two further readings 141 
were taken from each site, giving a total of three for each site.  142 
Treatment procedure 143 
All participants regardless of grouping had the same treatment procedure. Participants lay 144 
supine on the plinth with an ankle foot orthosis applied to both sides and the affected knee 145 
fully extended. The affected hip was flexed to the point of a change to symptoms, or if there 146 
was no change in symptoms, to the point where resistance prevented further movement. If 147 
symptoms were still not reproduced, medial rotation and adduction were added until  148 
symptoms occurred or resistance limited movement. The knee was then flexed until 149 
symptoms subsided (if present) and the treatment consisted of the knee being extended to 150 
the point of symptom onset or end range of resistance (if there were no symptoms) and then 151 
flexed again repeatedly (a knee joint mobilisation in SLR position). A grade III- to III+ 152 
mobilisation (large amplitude into tissue resistance 30, pg62 ) was performed. A treatment 153 
dose of 3 x 1 minute mobilisations was performed, with a 1 minute rest between 154 
mobilisations. The choice of treatment time has not been established to date for NDT, so 155 
was informed by clinical practice, and previously used by the researcher. 31 156 
PPT and VT were then retested as described above. 157 
Analyses 158 
Vibration threshold  159 
The mean of three appearance and 3 disappearance values were calculated to give the final 160 
VT reading. This follows the method of limits 32,33 and has excellent repeatability in 161 
individuals with spinally referred leg pain.34 162 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
Pressure pain threshold  163 
Three PPT readings were taken from each site. The first reading was discarded and the 164 
mean of the second and third measures used for the final reading of each site. This method 165 
was found to enhance the repeatability of PPT measures in individuals with spinally 166 
referred leg pain.34 167 
Data Analysis 168 
All comparable data was analysed to ensure normality using the Shapiro Wilk test. Baseline 169 
comparisons were made using Pearson’s correlation coefficients. Baseline differences were 170 
analysed by one way ANOVA or for non-normally distributed data Kruskall Wallis, and for 171 
nominal data Chi square test was used.  Differences between the 2 outcome measures, and 172 
between the 3 sub-groups were analysed using a 3 way mixed factorial ANOVA (time and 173 
site the within subject variables, and group the between subject variable) with subsequent 174 
covariate analysis to assess for any factors which may have influenced the outcomes. Post 175 
hoc testing was performed using Sidak corrected post hoc tests, unless indicated otherwise, 176 
and contrasts where appropriate. All p values were considered significant at p<0.05 level. 177 
 178 
RESULTS 179 
Sixty seven participants were involved in the study; 13 were recruited from Physiotherapy 180 
waiting lists, and 54 from outside of the NHS. Table 1 gives the demographic details of all 181 
participants. There were no baseline differences in any of the variables between groups 182 
except for age and pain below the knee. Post hoc testing of age using Gabriel’s pairwise 183 
test found no significant differences between the 3 sub-groups. For pain below the knee, the 184 
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somatic group, had a lower percentage of individuals with pain below the knee than 185 
radicular or radiculopathy groups. 186 
  Diagnostic sub-groups  
 Total Somatic Radicular Radiculopathy p 
N 67 11 33 23  
Age (years) 52.9 (13.3) 57.5 (10.6) 48.5 (13.2) 57 (13.1) 0.027*ᵃ 
Gender (% female) 49.3 54.5 51.5 43.5 0.78ᵇ 
Pain below knee (%) 70.1 18.2 75.8 87 0.000ᵇ 
Pain duration (years) 2.7 (4.9) 3.1 (5.9) 3.1 (5.7) 2 (2.8) 0.422ᵃ 
NHS Patients (%) 19.4 25 21.2 13.04 0.58ᵇ 
BMI 27.1 (4.6) 25.4 (3.6) 27.2 (4.9) 27.8 (4.6) 0.36ᵃ 
Disability (ODI) 17.3 (10.1) 16.3 (7.9) 17.5 (8.1) 17.4 (13.5) 0.94ᵃ 
Fear avoidance physical 
activity (FABQP) 
10.4 (4.9) 11.6 (4.2) 10.3 (4.8) 10.2 (5.5) 0.79ᵃ 
Fear avoidance work 
(FABQW) 
9.2 (8.4) 5.7 (7.2) 9.2 (9) 10.8 (7.9) 0.26ᵃ 
Pain Catastrophising (PCS) 
Total  
8.7 (8.9) 5.8 (3.8) 9.2 (8.9) 9.4 (10.5) 0.5ᵃ 
PCS Rumination 1 (5) 1 (4) 1 (5) 2 (6) 0.5c  
PCS Magnification 2 (3) 2 (2) 2 (3) 2 (2) 0.46c  
PCS Helplessness 2 (3) 2 (2) 2 (5) 2 (4) 0.71c   
Depression (DASS21) 1 (3) 1 (3) 1 (3) 1 (6) 0.72c   
Anxiety (DASS21) 1 (3) 1 (2) 2 (3) 1 (3) 0.69c   
Stress (DASS21) 4.8 (3.8) 3.9 (3.2) 5.3 (3.7) 4.5 (4.2) 0.54ᵃ 
Kinesiophobia (Tampa) 33 (10) 34 (10) 33 (10) 35 (11) 0.59c
 
 187 
TABLE 1 Baseline characteristics for the study participants 188 
ᵃOne Way ANOVA, data given is means and standard deviations   * post hoc testing revealed no sig 189 
diffs between groups (somatic v radicular p = 0.114, somatic v radiculopathy p = 0.999, radicular v 190 
radiculopathy p = 0.051). 191 
ᵇChi Square Test 192 
cKruskall Wallis, data not normally distributed and data given is median and interquartile ranges 193 
Key: BMI body mass index, ODI Oswestry disability scale, DASS disability anxiety and stress scale. 194 
 195 
 196 
 197 
 198 
 199 
 200 
 201 
 202 
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Pressure Pain Thresholds 203 
 204 
Mean (SD) pre and post SLR treatment PPT readings and mean differences (SD) can be 205 
found in Table 2. Very small differences in PPT can be seen for all sites and sub-groups. 206 
Large standard deviations, suggesting marked variation in response to SLR treatment 207 
between individuals were found. A cumulative proportion of responders analysis was 208 
performed (Figure 3) to further analyse the data 30 .  209 
 210 
Site Deltoid Tibial Nerve Gastrocnemius 
Group Pre Rx Post Rx Mean 
Diffs 
Pre Rx Post Rx Mean 
Diffs 
Pre  Rx Post Rx Mean 
Diffs 
Somatic 5.69 
(2.19) 
6.27 
(2.73) 
0.58 
(2.45) 
6.25 
(2.88) 
6.84 
(3.02) 
0.59 
(0.92) 
5.55 
(2.10) 
6.19 
(2.44) 
0.64 
(1.80) 
Radicular 4.59 
(2.33) 
4.4 
(2.08) 
-0.19 
(0.97) 
4.62 
(2.21) 
4.84 
(2.25) 
0.22 
(1.27) 
4.61 
(2.07) 
4.63 
(2.09) 
0.02 
(0.83) 
Radiculopathy 4.58 
(1.54) 
4.96 
(1.98) 
0.38 
(0.95) 
5.14 
(2.02) 
4.93 
(1.62) 
-0.21 
(1.26) 
5.02 
(1.78) 
4.78 
(1.94) 
-0.24 
(0.73) 
 211 
TABLE 2  Mean (SD) PPT for each site and for each sub-group of individuals with spinally 212 
referred leg pain. Key: Rx = treatment 213 
 214 
 215 
 216 
 217 
 218 
 219 
 220 
 221 
 222 
 223 
 224 
 225 
 226 
 227 
 228 
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 229 
 230 
 231 
FIGURE 3 Cumulative proportion of responders PPT (Kg) at deltoid (top), tibial nerve (middle) and 232 
gastrocnemius (bottom) site for each group 233 
 234 
 235 
 236 
 237 
 238 
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Statistical Analysis 239 
 240 
All data were normally distributed (Shapiro Wilk p >0.05), apart from the tibial nerve pre-241 
readings in the radicular group (p=0.009). Since only 1/18 readings reached statistical 242 
significance, and ANOVA is robust to alterations in normal distribution 35, pg 444, no 243 
transformations were carried out.  244 
 245 
Mauchly’s test of sphericity was not significant therefore sphericity was assumed. There 246 
was no main significant effect of group (F (2, 64) =2.77, p=0.07), or time (F (1, 64) = 2.46, 247 
p= 0.12) or site (F (2, 128) = 1.82, p= 0.16), and no significant interaction effects for time v 248 
site (F (2, 128) = 0.22, p= 0.8) or time v group (F (2, 64) = 1.92, p= 0.16). 249 
No significant correlations were found between the PPT readings and the psychosocial or 250 
disability factors, and no significant differences between groups at baseline, therefore no 251 
covariate analysis was performed. 252 
Vibration Thresholds 253 
 Missing data occurred in some participants due to equipment failure and erroneous 254 
readings over 20µm 36 (see Table 3 and figure 4). In the case of the missing data due to 255 
elevated VT readings, all participants were male and between the ages of 64-69 years.  256 
 257 
 258 
 259 
 260 
 261 
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Group Site N Reason 
Somatic Both 1 Equipment 
failure 
 1st Metatarsal 1 VT>20µm 
Radicular Both  1 VT>20µm 
 1st Metatarsal 1 VT>20µm 
Radiculopathy Both 1 Equipment 
failure 
 1st Metatarsal 1 VT>20µm 
 262 
TABLE 3 Missing vibration threshold data 263 
 264 
 265 
 266 
FIGURE 4 Final numbers of participants with collected vibration threshold (VT) data 267 
Key: LM vibration threshold from lateral malleolus 268 
 269 
Figure 5 shows the mean differences (before and after) measures for each site. It can be 270 
seen that there was a tendency for a reduction in VT in both the somatic and radiculopathy 271 
groups after treatment, but a slight increase in the radicular group. 272 
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 273 
FIGURE 5 Mean VT measures (µm) before and after treatment at the lateral malleolus and first 274 
metatarsal sites. The 95% confidence intervals demonstrate large variability in readings especially 275 
for the somatic and radiculopathy groups. 276 
Statistical Analysis  277 
All data were not normally distributed, (Shapiro Wilk test<0.05). A box-cox transformation 278 
(VTª)-1/a (where a=0.1) successfully normalised all but one of the readings. Since ANOVA 279 
is robust to minor violations of normality, this transformation was considered successful.  280 
There was a main effect for group (F (2, 57) = 4.79, p= 0.012). Sidak corrected post hoc 281 
tests indicated significantly higher VT for the radiculopathy compared to radicular group 282 
(p=0.01). There was a main significant effect for site (F (1, 57) = 38.17, p<0.01), but no 283 
other significant within subject effects (p>0.05).  284 
Correlation analysis using Pearson’s correlation (Table 4) showed significant strong 285 
correlations for VT with age. As age was strongly correlated with vibration thresholds, this 286 
interaction was entered into the analysis. No significant differences were seen for any 287 
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within or between subject analyses, indicating that the significantly higher VT in the 288 
radiculopathy group found in the first analysis was related to age.  289 
Variables Correlation 
coefficient 
P value Confidence 
interval 
r² 
VTLM pre : age 0.554  0.000 0.37-0.71 0.307 
VTLM post: age 0.501 0.000 0.31-0.67 0.25 
VT1MT pre: age 0.467 0.000 0.27-0.63 0.22 
VT1MT post: age 0.446 0.001 0.22-0.63 0.199 
 290 
TABLE 4  Pearson’s correlation between VT and age 291 
Key: VTLM vibration threshold from lateral malleolus, VT1MT vibration thresholds 1st 292 
metatarsal. 293 
 294 
There were no other significant correlations (p>0.05) between the psychosocial or disability 295 
factors and VT and no other baseline differences between groups therefore no further 296 
covariate analyses were performed. 297 
 298 
Central Sensitisation 299 
Only 2 participants were classified with CS, one within the radicular group and the other 300 
the radiculopathy group, therefore no meaningful analysis of this data could be attempted. 301 
 302 
DISCUSSION 303 
Pressure Pain Thresholds 304 
 No significant main or interaction effects were found, indicating that the 3 x 1 minute SLR 305 
treatment was not effective at reducing PPT in any of the 3 groups. The cumulative 306 
responders analysis was performed (Figure 3) because it allows for a more comprehensive 307 
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analysis of the response to treatment between groups 30. It has been suggested that a change 308 
in PPT over 15% may be clinically significant 37. At the deltoid site, over 40% of 309 
individuals in the somatic and radiculopathy groups showed an increase in PPT over 15%, 310 
but only around 25% in the radicular group. This trend reversed at the tibial nerve site with 311 
around 35% of individuals in the radicular group having increases of over 15%, whereas in 312 
the somatic and radiculopathy groups this fell to around 20% of participants. At 313 
gastrocnemius, less than 10% of participants in the radiculopathy group improved over 314 
15%, whereas 30% of participants in the radicular group and over 50% in the somatic group 315 
improved by over 15%.  Overall this suggests that a more positive effect on pain may have 316 
occurred in the somatic group, which is not the group in which this treatment would 317 
normally be chosen. Silva et al.10  also found no within subject differences in PPT after 318 
different durations of SLR treatment in individuals with sciatica, but significantly worse 319 
PPT in individuals with sciatica compared to a control group after 7 minutes of treatment. It 320 
is not known if longer treatment duration would have had such effects in the present study. 321 
Some limitations in the study design could account for the results of the present study. 322 
Firstly, it may have been useful to have measured the PPT over the most painful site where 323 
most change may have been expected. Secondly, it is possible that changes to pain may not 324 
occur immediately post treatment, but may be more apparent some hours or even days later. 325 
38,39
 Thirdly, treatment consisted of 1 session of 3 minutes of treatment; it is not known if 326 
this time is sufficient to cause changes to pain, particularly in individuals with  long-327 
standing symptoms.  328 
Vibration Thresholds 329 
No significant differences were found in VT between the groups or before and after 330 
treatment. Whilst there was a trend for a decrease in VT post treatment in radiculopathy and 331 
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somatic groups  and a slight increase in VT in the radicular group, these were mean 332 
differences, and individual variation meant that there were no significant differences 333 
overall.  334 
No beneficial effects of the NDT can be claimed, but importantly, no detrimental effects 335 
were found, even in individuals with altered neurological integrity. It has been suggested 336 
that applying tensioner techniques in individuals with neuropathy may be detrimental to 337 
nerve function 6,7 . The results of this study do not support such conclusions. Whilst it could 338 
be argued that the risk of accepting the results of the study may be due to the sample size, it 339 
is important to consider the large variation in the effect of SLR treatment on VT between 340 
individuals, some showing decreases and others increases in VT post treatment, which may 341 
have washed out any treatment effects. 342 
To the author’s knowledge, only one study has looked at the effects of a neural mobilisation 343 
on VT 31.  The findings of this study revealed no significant differences in asymptomatic 344 
participants, including a sub-group of runners. Since runners may be predisposed to 345 
neuropathy 40, 41, 42, the current study supports these findings.  Nee et al., 43 analysed 346 
adverse events in individuals after upper quadrant NDT. No differences in improvement 347 
occurred between those who reported an adverse event and those who did not. Whilst this 348 
study did not analyse changes to nerve conduction, it does suggest that adverse effects from 349 
NDT are short lived and not harmful.  350 
Central Sensitisation and other factors 351 
Only 2 participants were identified with CS, an unexpected finding considering the  352 
longevity of symptoms (mean 2.7 years) and the postulated relationship between chronic 353 
LBP and CS 26, 28, 44.  The method used to identify CS may not be sufficiently robust, 354 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
although this method is commonly used to identify CS in a number of conditions including 355 
fibromyalgia 45,46, 47. Another explanation could be that individuals with this condition may 356 
be reluctant to volunteer for a study which may induce pain. 357 
There were no correlations between PPT and VT and any of the psychological measures or 358 
disability scores. In addition, there were no significant differences in baseline measures 359 
between the groups. This suggests that these variables were not responsible for the outcome 360 
to the SLR treatment.  361 
 362 
CONCLUSION 363 
A 3 x 1 minute SLR treatment does not improve PPT in individuals with spinally referred 364 
leg pain, however it does not detrimentally affect VT. This suggests that nerve conduction 365 
is not altered after NDT even in individuals with signs of nerve function loss. Future work 366 
is essential to analyse optimal treatment doses and follow up times for outcome measures. 367 
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Highlights 
• A straight leg raise tensioner was given to people with spinally referred leg pain 
• Treatment duration was 3 x 1 minute 
• Pressure pain thresholds and vibration thresholds were the outcome measures 
• No statistical differences were found before and after treatment or between groups  
• Psychosocial factors, disability and central sensitisation didn’t alter outcomes  
 
